|Day Low/High||2.80 / 3.05|
|52 Wk Low/High||2.90 / 7.20|
The strength exhibited by the Russell 2000 paved the way for portfolio last week.
We threw in the towel last week on 2 positions and initiated a small stake in an ancillary cannabis play.
We’re cleaning house of Three-rated Inovio Pharma and Pixelworks and starting a small position in ancillary cannabis play Kush Bottles.
Marijuana stocks are still in their infancy, meaning there's a whole host of weed-adjacent stock moves waiting to be made. Here are the best bets.
You all likely know how I hate to chase a runner but that thought has become difficult to avoid.
At the same time we are raising Pixelworks' price target to $8 from $6.50.
Selloffs like the one in marijuana stocks present entry points, if this is your cup of tea.
Here's a look at biotech stock trades, takeout targets and pot sellers that will dominate 2018.
Recreational use of marijuana is now legal in California, but don't get lost among the weeds of stocks.
Consumers in California eagerly await the end to it prohibition on the recreational use of cannabis.
On Monday, recreational use of marijuana will be legal in California, so let's visit 3 weed stocks.
The cannabis industry is growing but isn't easy to work with, said Kush CEO Nick Kovacevich. But the company is carving a new niche -- and growing fast.
Marijuana legalization advocates and industry actors remain optimistic about the incoming Trump administration's attitude towards pot, despite some less-than-reassuring comments from Jeff Sessions.
The cannabis industry is adding jobs in America for a product that is now legally bought and sold. So why wouldn't Donald Trump want to be the 'marijuana president'?
Growth is almost guaranteed in these two areas, says James McDonald of Index Strategy Advisors.
Cannabis stocks listed on the Nasdaq continued to rally after voters ended prohibition and approved the recreational use of marijuana in California, Massachusetts, Maine and Nevada.
Marijuana is on the ballot in several states this election cycle, and its approval could be a boon for those in the business -- though obstacles remain.
It may not be the likeliest of scenarios, but if Gary Johnson becomes president of the United States, investors might want to shift some money around. Here's how.
The marijuana boom is only in its 'second inning' and the map is wide open for innovative cannabis companies seeking to establish themselves.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.